A New Delhi metallo-β-lactamase (NDM)-positive isolate of Klebsiella pneumoniae causing catheter-related bloodstream infection in an ambulatory hemodialysis patient

Codjoe, 2017, Carbapenem resistance: a review, Med Sci, 6 Wu, 2019, NDM metallo-beta-lactamases and their bacterial producers in health care settings, Clin Microbiol Rev, 32, 10.1128/CMR.00115-18 D’Agata, 2018, Addressing the problem of multidrug-resistant organisms in dialysis, Clin J Am Soc Nephrol, 13, 666, 10.2215/CJN.13781217 Mermel, 2009, Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America, Clin Infect Dis, 49, 1, 10.1086/599376 Bush, 2018, Past and present perspectives on beta-lactamases, Antimicrob Agents Chemother, 62, 10.1128/AAC.01076-18 Sheu, 2019, Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options, Front Microbiol, 10, 80, 10.3389/fmicb.2019.00080 Rotondo, 2017, Inhibitors of metallo-beta-lactamases, Curr Opin Microbiol, 39, 96, 10.1016/j.mib.2017.10.026 Moya, 2019, In vitro and in vivo activities of beta-lactams in combination with the novel beta-lactam enhancers zidebactam and WCK 5153 against multidrug-resistant metallo-beta-lactamase-producing Klebsiella pneumoniae, Antimicrob Agents Chemother, 63, 10.1128/AAC.00128-19 Emeraud, 2019, Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-beta-lactamase-producing gram-negative bacteria, Antimicrob Agents Chemother, 63, 10.1128/AAC.00010-19 Sader, 2018, Antimicrobial activities of aztreonam-avibactam and comparator agents against contemporary (2016) clinical Enterobacteriaceae isolates, Antimicrob Agents Chemother, 62, 10.1128/AAC.01856-17 Biagi, 2019, Searching for the optimal treatment for metallo- and serine-beta-lactamase producing Enterobacteriaceae: aztreonam in combination with ceftazidime-avibactam or meropenem-vaborbactam, Antimicrob Agents Chemother, 30 Zhanel, 2019, Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative bacilli, Drugs, 79, 271, 10.1007/s40265-019-1055-2 McKinnell, 2019, Plazomicin for infections caused by carbapenem-resistant Enterobacteriaceae, N Engl J Med, 380, 791, 10.1056/NEJMc1807634 Serio, 2019, Plazomicin is active against metallo-beta-lactamase-producing Enterobacteriaceae, Open Forum Infect Dis, 6, 10.1093/ofid/ofz123 Lee, 2019, Eravacycline, a newly approved fluorocycline, Eur J Clin Microbiol Infect Dis, 38, 1787, 10.1007/s10096-019-03590-3 Millson, 2019, A demonstration project on the impact of safety culture on infection control practices in hemodialysis, Am J Infect Control, 47, 1122, 10.1016/j.ajic.2019.02.026 Lindberg, 2019, Advancing antimicrobial stewardship in outpatient dialysis centers using the positive deviance process, Nephrol Nurs J, 46, 511 Eilertson, 2017, Carbapenem-resistant Enterobacteriaceae infections in patients on renal replacement therapy, Open Forum Infect Dis, 4, 10.1093/ofid/ofx216 Bleumin, 2012, Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients, J Infect, 65, 318, 10.1016/j.jinf.2012.06.005 Zmarlicka, 2015, Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics, Infect Drug Resist, 8, 297